COMPARISON OF CHEMOTHERAPY REGIMENS IN CHILDREN WITH RHABDOMYOSARCOMA

横纹肌肉瘤儿童化疗方案的比较

• 批准号: 7607544
• 负责人: YOUSIF H MATLOUB
• 金额: $ 0.24万
• 依托单位: UNIVERSITY OF WISCONSIN-MADISON
• 依托单位国家: 美国
• 财政年份: 2006
• 资助国家: 美国
• 起止时间: 2006-12-01 至 2007-09-16
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7607544
• 关键词: Chemotherapy-Oncologic Procedure; Child; Computer Retrieval of Information on Scientific Projects Database; Drug usage; Funding; Grant; Institution; Patients; Pharmaceutical Preparations; Phase II Clinical Trials; Randomized; Recruitment Activity; Research; Research Personnel; Resources; Rhabdomyosarcoma; Source; United States National Institutes of Health; Work; chemotherapy; compare effectiveness; killings; neoplastic cell

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This study is no longer recruiting patients. [from ClinicalTrials.gov website (edited)] Drugs used in chemotherapy work in different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. This is a randomized Phase II trial to compare the effectiveness of different combination chemotherapy regimens in treating children who have rhabdomyosarcoma.

该副本是利用众多研究子项目之一 由NIH/NCRR资助的中心赠款提供的资源。子弹和 调查员（PI）可能已经从其他NIH来源获得了主要资金， 因此可以在其他清晰的条目中代表。列出的机构是 对于中心，这不一定是调查员的机构。 这项研究不再招募患者。 [来自ClinicalTrials.gov网站（编辑）] 化学疗法中使用的药物以不同的方式工作，以阻止肿瘤细胞分裂，从而停止生长或死亡。组合多种药物可能会杀死更多的肿瘤细胞。 这是一项随机II期试验，用于比较不同组合化疗方案在治疗患有横纹肌肉瘤的儿童中的有效性。